LivingGLP1
Study S001482

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function - the PIANO Study

Registration

Registration
NCT06608433
Acronym
PIANO
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
TRIPLE
Status
COMPLETED
Enrollment
22
Start
2025-01-16
Primary completion
2025-10-31
Lead sponsor
University Hospital, Basel, Switzerland
Conditions
Healthy Volunteer Study; HPA; Cortisol Deficiency; Adrenal Insufficiency
Interventions
DRUG:semaglutide; DRUG:Placebo
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Change in serum cortisol after Rybelsus vs. Placebo [within 210 minutes after the intake of the study drug]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.